BCLAF1抑制了造血干细胞的应激反应,以支持扩张和重新繁殖
Stephanie J Crowley1, Wei Yang2, Lynn S White1
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Blood advances
|May 28, 2025
概括
乙细胞淋巴瘤-2-关联因子1 (BCLAF1) 对于造血干细胞 (HSC) 的扩张和重新繁殖至关重要. 丢失BCLAF1会损害HSC的自我更新和应激反应,影响胎儿发育和移植成功.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 发育生物学 发展生物学
背景情况:
- 造血干细胞 (HSC) 对于血液形成至关重要,并在胎儿发育和压力期间迅速扩大.
- 调节HSC扩张和重新种植活动对于开发和移植成功至关重要.
研究的目的:
- 为了确定血造干细胞 (HSC) 重新繁殖活动的新型调节者.
- 研究B细胞淋巴瘤-2-关联因子1 (BCLAF1) 在HSC扩张和造血细胞复合中的作用.
主要方法:
- 在小鼠中,Bclaf1的血液构造特异性和可诱导的删除.
- 胎儿血液生成原始体的单细胞RNA测序.
- 分析HSC自我更新和多系复合活性.
主要成果:
- BCLAF1促进胎儿的HSC发育,但对于成人HSC保持稳定状态是不可或缺的.
- 失去BCLAF1会影响移植后的HSC自我更新和多系复合.
- 缺乏BCLAF1会降低长期的HSC,并抑制胎儿前的压力反应基因表达.
结论:
- BCLAF1是一种新型调节器,可以调节高血糖细胞的再生活动.
- BCLAF1在胚胎发生和干细胞移植后的再生功能过程中,在维护HSC发育方面发挥着至关重要的作用.
- BCLAF1限制HSC中的压力反应,保持其功能.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Lineage Commitment
3.2K
Commitment is the process whereby stem cells:
3.2K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Renewal of Intestinal Stem Cells
2.7K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
Production of Formed Elements
1.8K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.8K


